OrthoPediatrics Reports 3Q18 Revenue of $15.8MM, +27.8% vs. 3Q17

OrthoPediatrics continues growth with another quarter of record revenues, reports US $15.8MM in 3Q18 sales, +27.8% vs. 3Q17.

Member-Only Content

ConforMIS posts 3Q18 product revenue of US $18.3MM, +0.9% vs 3Q17.

Integra LifeSciences reports 3Q18 results; ORTHOWORLD estimates orthopaedic revenue of $22.7M, -0.8% vs. 3Q17.

Sanofi Synvisc/Synvisc-One orthobiologics revenue continues to slide, accounting for €72MM (USD $88.7MM) 3Q18 revenue, -24.2% vs. 3Q17.

NuVasive performance driven by increased case volume and new products, posts 3Q18 revenue of US $271.3MM, +9.6%vs. 3Q17.

Zimmer Biomet appointed Mr. Ivan Tornos as Group President, Orthopedics, effective November 1.

Orthofix performance driven by bone growth and trauma products with 3Q18 revenue of US $111.7MM, +6.1% vs. 3Q17.

Zimmer Biomet keeps pace with recovery efforts, posts 3Q18 orthopaedic revenue of US $1,637.4MM, +1.2% vs. 3Q17.

Momentum in knee reconstruction drove Stryker's 3Q18 orthopaedic performance, with revenue of US $1,689.7MM, +4.2% vs. 3Q17.

Camber Spine announced the milestone of US $1MM with the SPIRA-C cervical interbody implant in less than six months.